Pregnant women with epilepsy are at increased risk of death and complications from seizures; their high-risk status during pregnancy and after childbirth is often not recognised. The researchers in this study developed the EMPiRE model to predict the risk of seizures in pregnancy and up to 6 weeks after delivery in women with epilepsy on medication whose drug doses were managed based on clinical findings. The model was validated in a separate group of women whose dose management was based on drug levels in the blood.
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.